This sounds relatively easy to roll out as a test for all potentially affected patients? Regardless, interesting research!
Except that the tests for these clots are not routine and most health systems are not setup for that degree of testing of this nature. They are not standard blood tests like most places can easily perform.
I understand that, it's written in the article, but it doesn't seem to me as problematic as doing an MRI for example.
No doubt you are correct about that. I wonder what the overhead of these tests are.